REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Genvital S.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Secondary Activities: Medicinal and Botanical Manufacturing
Full name: Genvital S.A. Profile Updated: April 07, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Genvital S.A. is a company based in Ecuador, with its head office in Guayaquil. It operates in the Pharmaceutical and Medicine Manufacturing industry. The enterprise was incorporated on December 01, 2015. It currently has a total number of 2 (2024) employees. From the latest financial highlights, Genvital S.A. reported a net sales revenue drop of 75% in 2025. Its’ total assets recorded a negative growth of 2.25%. The net profit margin of Genvital S.A. decreased by 27.3% in 2025.

Headquarters
Av. Carlos Julio Arosemena, 2.5
Guayaquil; Guayas;

Contact Details: Purchase the Genvital S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Genvital S.A. report to view the information.
Registered Capital:
Purchase the Genvital S.A. report to view the information.
Financial Auditors:
Purchase the Genvital S.A. report to view the information.
Incorporation Date:
December 01, 2015
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
40%
Purchase this report to view the information.
40%
Purchase this report to view the information.
20%
Subsidiaries
Indeurec S.A.
2.12%
Company Performance
Financial values in the chart are available after Genvital S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-75%▼
Total Operating Revenue
-75%▼
Operating Profit
-89.4%▼
EBITDA
-89.4%▼
Net Profit/Loss for the Period
-89.7%▼
Total Assets
-2.25%▼
Total Equity
3.36%▲
Operating Profit Margin
-40.36%▼
Net Profit Margin
-27.3%▼
Return on Equity (ROE)
-29.4%▼
Quick Ratio
-0.34%▼
Cash Ratio
0.12%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo